Patent · US Active

Application of highly conserved domain sequences from viral genome as template to design therapeutic sliRNAs

US9284560B2 · kind B2 · utility

0Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 19, 2011
Grant dateMar 15, 2016
Priority date
Expiry dateSep 19, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to the application of the highly conserved sequences of viral genome, especially from a highly conserved domain of enteroviral genome as templates to design target small ligand RNAs (sliRNAs). The resulting sliRNAs are therapeutically active ingredients in the treatment of the related diseases caused by pathological angiogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.